新西兰看到,由于廉价、普遍供应、健康和社会问题恶化,甲基安非他明和可卡因使用率不断上升。 New Zealand sees rising meth and cocaine use due to cheap, widespread supply, worsening health and social issues.

新西兰2025年毒品趋势调查显示,甲基安非他明和可卡因使用量在历史低价格的推动下急剧上升——按实际价值计算,2017年以来下降了55%,每周或更频繁的使用量几乎翻了一番,达到57%。 New Zealand's 2025 Drug Trends Survey reveals a sharp rise in methamphetamine and cocaine use, driven by historically low prices—meth dropped 55% in real terms since 2017, with weekly or more frequent use nearly doubling to 57%. 无障碍程度的提高导致消费增加,特别是低收入和年轻用户的消费增加,健康和社会伤害恶化,如精神疾病和家庭暴力。 Increased accessibility has led to higher consumption, particularly among low-income and younger users, worsening health and social harms like psychosis and family violence. 可卡因的使用也达到了创纪录的高水平,43%的用户报告容易获得可卡因,尽管与甲基安非他明相比,可卡因的使用仍然不那么普遍。 Cocaine use is also at a record high, with 43% of users reporting easy access, though it remains less common than meth. 尽管缉获了大量毒品,但通过包括墨西哥卡特尔和太平洋岛屿路线在内的跨国网络,供应正在不断扩大。 Supply is expanding via transnational networks, including Mexican cartels and Pacific Island routes, despite major seizures. 调查结果突显了日益增长的公共卫生关切,以及迫切需要改进数据、减少危害和采取对策。 The findings highlight growing public health concerns and the urgent need for improved data, harm reduction, and policy responses.